Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth

Core Viewpoint - Niagen Bioscience, Inc. has raised its full-year 2025 net sales outlook to a growth rate of 25% to 30% year-over-year, up from a previous estimate of 22% to 27% [1] Company Summary - Niagen Bioscience, Inc. is recognized as a global authority on NAD+ (nicotinamide adenine dinucleotide) and focuses on the science of healthy aging [1] - The company emphasizes the importance of elevating NAD+ levels for health, particularly as individuals age, highlighting the significance of this area of science for public health [1]